Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.
Press releases published on October 7, 2025
Independent Payer Study Confirms FIGUR8 System Sets New Standard in Workers’ Compensation Care
Independent study with a Top 10 national workers’ compensation payer demonstrates double-digit cost savings and improved return-to-work outcomes. BOSTON, MA, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- Independent Payer Study Confirms FIGUR8 …
The Alliance of Independent Dentists Announces Second Annual National Symposium in Naples, FL
March 2026 event provides premier opportunity for education and networking HOPKINTON, MA, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- The Alliance of Independent Dentists (AID) is pleased to announce its upcoming AID National Symposium, March …
Bierman Autism Centers Hosts Free Sensory-Friendly Trunk-or-Treat Events Nationwide This October
Inclusive Halloween Celebrations Designed for Kids with Autism and Their Families NEEDHAM, MA, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- This October, Bierman Autism Centers will bring its beloved sensory-friendly Trunk-or-Treat events to …
Triumph Steps Expands Emotional Literacy Programs to Schools Nationwide
Miami, Florida , Oct. 07, 2025 (GLOBE NEWSWIRE) -- Triumph Steps, an emotional literacy platform trusted by professionals and communities, today announced the national rollout of Triumph Steps for Schools, a comprehensive K–12 initiative designed to foster …
Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners
CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
WEST CHESTER, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that it …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Neurona Expands Investigation of NRTX-1001 Cell Therapy into Mesial Temporal Lobe Epilepsy (MTLE) without Mesial Temporal Sclerosis (MTS)
- First subject received unilateral administration of NRTX-1001 in a new non-MTS cohort; no significant surgical complications or adverse events reported to date - - Data from this non-MTS cohort, together with results from Neurona’s ongoing Phase 1/2 …
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Nature’s Sunshine Relaunches Revolutionary Power Line to Combat Metabolic Health Crisis
LEHI, Utah, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company that manufactures high quality herbal and nutritional products, announced the relaunch of its Power Line suite of …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia and BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing …
Inventiva présentera plusieurs abstracts lors du congrès AASLD The Liver Meeting® 2025
Présentation d’une comparaison entre histologie numérique et sur lame des biopsies de screening de l’étude de Phase 3 NATiV3 Présentation de pathologie numérique de données précliniques avec lanifibranor Daix (France), New York City (New York, United …
Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025
Presentation of a comparison between digital and glass slide histology from screening biopsies in the Phase 3 NATiV3 study Presentation of digital pathology data from preclinical studies with lanifibranor Daix (France), New York City (New York, United …
AAVantgarde announces 3 presentations at ESGCT 2025 annual meeting
MILAN, Oct. 07, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced three presentations at the European Society of Gene …
NJ-Founded MetasTx Fast-Tracks Precision Approach to Stop Prostate Cancer Spread; NCI-Backed Diagnostic in Proof-of-Concept, Next-Gen KIT Inhibitor Advancing Toward First-in-Human
PITTSBURGH, Oct. 07, 2025 (GLOBE NEWSWIRE) -- MetasTx, an early-stage biotech originally founded in New Jersey and now headquartered in Pittsburgh, announced progress on its two-part precision oncology platform designed to identify and treat men with …
Intermountain Primary Children’s Hospital Ranked as One of the Nation’s Best Pediatric Hospitals in Every Category by U.S. News & World Report
SALT LAKE CITY, Oct. 07, 2025 (GLOBE NEWSWIRE) -- A Utah medical milestone has been achieved by Intermountain Primary Children’s Hospital – one that directly benefits children and families throughout the Intermountain West. For the second consecutive year …
Obesity Surgery Program Led by Dr. Mesut Caynak Expands Adoption of the ‘Caynak Technique’; SRC Master Accreditation Renewed
Photo: Dr. Mesut Caynak ANTALYA, Turkey, Oct. 07, 2025 (GLOBE NEWSWIRE) -- The bariatric and metabolic surgery program led by Dr. Mesut Caynak announced the broader clinical adoption of the “Caynak Technique”, a systems-based, protocolized model for …
Herantis Pharma presents positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease
Herantis Pharma announces positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease Trial meets all primary and secondary endpoints establishing a strong foundation to Phase 2 The clinical trial demonstrated that both …
Global Insulin Delivery Devices Market is Predicted to Reach ~USD 53 Billion by 2032 | DelveInsight
New York, USA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Global Insulin Delivery Devices Market is Predicted to Reach ~USD 53 Billion by 2032 | DelveInsight The insulin delivery device market is primarily propelled by the growing incidence of diabetes, a shift …